WNT5A and rheumatoid arthritis: Our results indicate that WNT5A contributes to the aggressive phenotype of the FLS in RA patients because it promotes their enhanced migration and invasion, and the expression of inflammatory mediators via the WNT/Ca2+ and RYK/RhoA/ROCK signaling pathways (Figure 8).